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ABSTRACT: Physical activity and exercise training are effective 
strategies for reducing the risk of cardiovascular events, but 
multiple studies have reported an increased prevalence of coronary 
atherosclerosis, usually measured as coronary artery calcification, 
among athletes who are middle-aged and older. Our review of the 
medical literature demonstrates that the prevalence of coronary 
artery calcification and atherosclerotic plaques, which are strong 
predictors for future cardiovascular morbidity and mortality, was 
higher in athletes compared with controls, and was higher in the 
most active athletes compared with less active athletes. However, 
analysis of plaque morphology revealed fewer mixed plaques and 
more often only calcified plaques among athletes, suggesting a more 
benign composition of atherosclerotic plaques. This review describes 
the effects of physical activity and exercise training on coronary 
atherosclerosis in athletes who are middle-aged and older and aims 
to contribute to the understanding of the potential adverse effects 
of the highest doses of exercise training on the coronary arteries. 
For this purpose, we will review the association between exercise 
and coronary atherosclerosis measured using computed tomography, 
discuss the potential underlying mechanisms for exercise-induced 
coronary atherosclerosis, determine the clinical relevance of coronary 
atherosclerosis in middle-aged athletes and describe strategies for the 
clinical management of athletes with coronary atherosclerosis to guide 
physicians in clinical decision making and treatment of athletes with 
elevated coronary artery calcification scores.
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published on behalf of the American 
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access article under the terms of 
the Creative Commons Attribution 
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Cardiovascular diseases (CVDs) are the dominant cause of death worldwide, accounting for ap-proximately 18 million deaths per year (31% of 
total mortality).1 Atherosclerotic coronary heart disease 
is the leading cause of deaths attributable to CVD and 
accounts for almost 45% of all cases. There is clear evi-
dence that chronic physical activity and exercise training 
significantly reduce the risk for cardiovascular events.2 
However, several recent studies have suggested that 
high-volume, high-intensity exercise training may ac-
tually increase the prevalence and severity of coronary 
atherosclerosis.3–5 Of note, analysis of plaque morphol-
ogy has shown fewer mixed plaques and more often 
only calcified plaques in the athletes, suggesting a more 
stable atherosclerotic pattern. The mechanisms leading 
to increased coronary atherosclerosis in athletes are 
largely unknown. Furthermore, the clinical relevance of 
these findings and how to manage athletes with coro-
nary atherosclerosis are unclear. In this review we de-
scribe the short-term and long-term effects of exercise 
training on coronary atherosclerosis in athletes who are 
middle-aged and older. This review will summarize the 
association between exercise and coronary atheroscle-
rosis measured using computed tomography (CT), dis-
cuss the potential underlying mechanisms, determine 
the clinical relevance of atherosclerosis in middle-aged 
athletes, and describe strategies for managing athletes 
with coronary atherosclerosis.
METHODS TO ASSESS CORONARY 
ATHEROSCLEROSIS CHARACTERISTICS
Two different CT-scan protocols can be used for the assess-
ment of coronary atherosclerosis. A noncontrast CT-scan 
demonstrates the amount of coronary artery calcification 
(CAC), which is expressed as a CAC score (CACS) in Agatston 
units.6 The CACS is predictive of future CVD events.7,8 The 
CACS is the product of CAC volume and CAC density, and 
although CAC volume has a positive association with cardio-
vascular events, CAC density is inversely associated with car-
diovascular events,9 suggesting that not all CACS have the 
same risk. Coronary CT angiography (CCTA) uses contrast to 
assess luminal stenoses, plaque characteristics, and plaque 
volume. Luminal stenoses are visually graded and significant 
stenoses (>50%) are strongly associated with cardiovascu-
lar events.10 The number of segments affected can also be 
summed to produce a segment involvement score, which is 
a strong predictor of events.11 Both CACS and CCTA derived 
scores predict events, but the addition of the number, loca-
tion, and severity of stenoses from CCTA does not appear to 
improve event prediction more than standard risk factors and 
CACS in asymptomatic patients,12 suggesting that CACS is 
as good a predictor of cardiovascular events in such patients.
Plaques can be characterized as calcified, noncalcified, 
or mixed (containing both calcified and noncalcified mate-
rial) plaques, with a distinct difference in prognosis. Mixed 
plaques are associated with the worst prognosis, whereas cal-
cified plaques are associated with the best event-free survival, 
and noncalcified plaques have an associated risk in between 
the other 2 types.13 CCTA also allows the identification of 
potentially high-risk plaque features such as the napkin ring 
sign (a ring of high attenuation around a low-attenuation 
plaque suggesting atheroma with a thin fibrous cap), vessel 
expansion or positive remodeling, low (<30) Hounsfield unit 
plaque suggesting lipid enrichment, and spotty calcification.14 
CCTA plaque characteristics and high-risk plaque features are 
good predictors of CVD risk,13,15 although the spatial resolu-
tion of CT-scans is too low to reliably identify the most vulner-
able (thin-cap) plaques.16 New software allows quantification 
of plaque volume which will likely improve understanding and 
risk prediction of coronary atherosclerosis.17
EXERCISE AND CORONARY 
ATHEROSCLEROSIS
Findings in the General Population
Physical activity is defined as any bodily movement that 
results in energy expenditure beyond resting levels,18 
and is often quantified as Metabolic Equivalent of Task 
(MET) minutes or hours per week. Physical activity can 
include activities at work, during commuting, or during 
recreation. 
Regular physical activity and exercise improves car-
diovascular risk factors including blood pressure, serum 
lipid profile, glucose control, and cardiovascular func-
tion, but studies examining the relationship between 
physical activity and CAC have reported an inverse re-
lationship (n=8 studies),19–26 positive relationship (n=2 
studies),24,27 U/J-shaped relationship (n=3 studies),23,25,26 
or no relationship (n=7 studies, Table I in the Data 
Supplement).19,20,28–32 Population cohorts have demon-
strated a wide prevalence of CAC (CACS>0) ranging 
from 29%27 to 93%20. This variation in CAC prevalence 
is partly attributable to differences in age, sex, and 
cardiovascular risk factors. For example, women aged 
74±4 years had a prevalence of CAC of 74%,20 where-
as women aged 62±4 years had a CAC prevalence of 
40%.20 CAC prevalence differs among physical activity 
categories (Figure 1A), but not after adjustment for po-
tential confounders (Figure 1B). No clear sex differences 
were observed in the association between physical ac-
tivity and CAC.
The variability in outcomes, in studies of the rela-
tionship between physical activity and CAC, may also 
be a result of the methods used to measure physical 
activity. For example, a study showed that physical ac-
tivity measured by accelerometer was inversely associ-
ated with CACS, but there was no association when 
levels of physical activity were determined with sub-
jective questionnaires.19 The quality of questionnaires, 
whether past or current activity is measured, and if total 
activity or only intentional exercise is measured could 
also impact findings. The spectrum of physical activity 
levels in the study population may also affect results 
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because an inverse relationship was found at low lev-
els of physical activity22 and a positive relationship was 
found at the highest physical activity levels,27 suggest-
ing a difference in the relationship between physical 
activity and CAC at different activity levels. Finally, dif-
ferences in age of the participants may also contribute 
to the conflicting findings, as an inverse association was 
found between physical activity and CACS among older 
(74±4 years) postmenopausal women where there was 
no significant association in younger (57±3 years) post-
menopausal women.20 This may be because of the age- 
and sex-dependence of CAC with a low prevalence in 
middle-aged women.33
Similar associations were observed between CAC 
and cardiorespiratory fitness. Cardiorespiratory fitness 
comprises a set of attributes that individuals inherit or 
achieve through exercise training that is measured by 
their ability to perform physical activity.18 Several Korean 
studies found an inverse association between cardiore-
spiratory fitness and CAC among mainly middle-aged 
men.34–36 Similar results were found in middle-aged 
women from the Cooper Clinic,37 however the ob-
served modest inverse relationship between fitness and 
CAC was no longer significant after adjustment for tra-
ditional risk factors. In contrast, the CARDIA study (Cor-
onary Artery Risk Development in Young Adults) found 
a positive association between cardiorespiratory fitness 
and CAC in young adults followed for 27 years,38 which 
disappeared after multivariate adjustment. Kermott et 
al found a reverse J-shaped association between cardio-
respiratory fitness and CAC prevalence in middle-aged 
men, with an increased CAC prevalence in the fittest 
group.39 This effect remained significant after adjust-
ment for some variables (age, body mass index, and 
family history), but did not include a full adjustment 
for potential confounders. Adjustment for confound-
ing factors plays an important role in the association 
between physical activity, cardiorespiratory fitness, and 
CAC. Therefore, adequate and clearly described adjust-
ment of confounding factors is important when pre-
senting and interpreting the results. Taken together, 
studies assessing the relationship between physical 
activity, cardiorespiratory fitness, and CAC have shown 
mixed results, potentially because of differences in 
study population and methods, with no clear net effect 
toward either a positive or inverse association.
Endurance Exercise Training
Exercise is a subset of physical activity that is planned, 
structured, repetitive, and intended to improve or main-
tain physical fitness.18 Endurance exercise training refers 
to repetitively performing aerobic physical activity, such 
as running or cycling, to obtain a training adaptation.
Lin et al studied the acute effects of endurance ex-
ercise on coronary atherosclerosis characteristics in 8 
participants of the Race Across the USA (a 140-day 
foot race).40 Four runners had at least 1 cardiovascular 
risk factor and coronary atherosclerosis at baseline, and 
showed increases in noncalcified plaque volume after 
the race.40 Runners with no baseline coronary athero-
sclerosis remained free of coronary atherosclerosis after 
the race. Although the numbers are small, these data 
raise the possibility that high-volume endurance exer-
cise may accelerate coronary atherosclerosis in vulner-
able individuals.
Most studies have assessed the long-term effect of 
endurance exercise training on coronary atherosclerosis 
Figure 1. Prevalence of coronary artery calcification in the general population.
Studies reporting coronary artery calcification (CAC) prevalence and adjusted odds ratios for the association between physical activity and CAC are shown.20,22,27,30 
A, Percentage of CAC prevalence (CAC Score [CACS]>0) across physical activity/exercise groups. B, Adjusted odds ratios for CAC prevalence across physical 
activity/exercise groups. In B, Desai et al (blue color) included 520 men and 259 women, but the sample size per physical activity categories was not reported. In 
summary, there is no clear net effect toward either a positive or inverse association between physical activity volumes and CAC prevalence in general population 
studies. MET indicates metabolic equivalent of task; and PA, physical activity.
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(Table II in the Data Supplement). Figure 2 summarizes 
the findings of studies that compared the prevalence of 
CAC between athletes and less active individuals. CAC 
is present in 34% to 71% of athletic cohorts (Figure 2A) 
and 11% to 36% have CACS≥100, a value often used 
to signify increased risk (Figure 2B). Differences in age 
and cardiovascular risk factors contribute to this vari-
ability. For example, CAC was present in 71% of 108 
male marathon runners (57±6 years old), of whom 
12% had a history of hypertension, and 57% were cur-
rent (4.6%) or former (52%) smokers,3 whereas CAC 
was present in only 48% of 106 male athletes (54±9 
years old) without cardiovascular risk factors.5
Only 1 of 3 studies found a higher prevalence of CAC 
among the most active athletes (Figure  2A). Aenge-
vaeren et al divided 284 male athletes into 3 groups on 
the basis of their lifelong exercise volume.4 CAC prev-
alence was higher in the most active athletes (>2000 
MET-min/week; adjusted odds ratio [ORadjusted] 3.2 [95% 
CI, 1.6–6.6]) compared with the least active athletes 
(<1000 MET-min/week), but there was no difference in 
CAC area, density, and number of lesions among exer-
cise volume groups in those with CAC.4 Möhlenkamp et 
al compared 108 male marathon runners with 864 age-
matched controls and 216 age and risk factor–matched 
controls.3 CAC prevalence was lower in the marathon 
runners versus age-matched controls but did not differ 
when matched for age and cardiovascular risk factors. 
Merghani et al found no difference in the prevalence 
of CAC between 106 male athletes (≥10 miles of run-
ning or ≥30 miles of cycling per week for ≥10 years) 
and 54 male controls (median of 1.5 hours of exercise 
per week), all without cardiovascular risk factors.5 In 
contrast to Aengevaeren et al, Möhlenkamp et al, and 
Merghani et al did report higher CACS in athletes with 
CAC compared with controls with CAC (Figure 2C).
Figure 2. Prevalence of coronary artery calcification and coronary artery calcification scores in studies comparing male athletes with controls.
A, Prevalence of coronary artery calcification (CAC) scores (CACS) >0 within athletic and control subjects.3–5 B, Prevalence of CACS >100.3-5, 41 C, CACS within 
those individuals with prevalent CAC.3–5 These data illustrate increased CAC in the most active athletes. AU indicates arbitrary units; MET, metabolic equivalent of 
task; and RF, risk factors. 
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Three of 4 studies revealed a greater prevalence of 
CACS≥100 in more active subjects, and the fourth study 
showed a trend approaching significance (P=0.06, Fig-
ure 2B). For example, among 21 758 men divided into 
3 groups on the basis of their physical activity volumes 
(<1500 MET-min/week, 1500–2999 MET-min/week, 
and ≥3000 MET-min/week),41 the most active individu-
als had an 11% greater risk for CACS ≥100 compared 
with those accumulating <3000 MET-min/week (relative 
risk [RR] 1.11 [95%CI, 1.03–1.20]). Despite the higher 
risk of CACS ≥100 for the most active individuals, CAC 
volume, density, and number of lesions did not differ 
between physical activity groups within each category 
of CAC (CACS ≥100 and <100).
Using CCTA, an American study compared 50 mara-
thon runners with 23 sedentary controls who under-
went CCTA for clinical indications and found signifi-
cantly higher plaque volume, both calcified (83.8±67.7 
mm3 versus 44.0±36.8 mm, P<0.0001)3 and noncalci-
fied (116.1±95.7 mm3 versus 81.5±58.1 mm3, P=0.04), 
in the runners,42 but the runners were older (59±7 ver-
sus 55±10 years, P=0.051) than the controls. The British 
study found an increased prevalence of atherosclerotic 
plaques in male athletes (44%) versus controls (22%, 
P=0.01),5 but found no differences among female 
study participants. The Dutch study found an increased 
plaque prevalence in the most active (77%; ORadjusted 3.3 
[95% CI, 1.6–7.1]) versus the least active (56%) male 
middle-aged athletes. In both the British and Dutch 
studies, the most active individuals had a more benign 
atherosclerotic plaque composition, with fewer mixed 
plaques and a higher prevalence of only having calci-
fied plaques (Figure 3).4,5 Exercise intensity and sporting 
discipline may also affect the results. Only very vigorous 
exercise (≥9 MET) was associated with atherosclerotic 
plaque (OR 1.56 per hour/week [95% CI, 1.17–2.08]) 
and CAC prevalence (OR 1.47 per hour/week [95% CI, 
1.14–1.91]) in the Dutch study.4 Moreover, cyclists ap-
peared to have a lower risk of atherosclerotic plaque 
(OR 0.41 [95% CI, 0.19–0.87]) and CAC (OR 0.55 
[95% CI, 0.26–1.16]) compared with runners and in-
dividuals performing other sports (eg, soccer, hockey, 
water polo).43
Future longitudinal studies are required to investi-
gate whether CAC progression is accelerated in ath-
letes. Although the studies in endurance athletes are 
relatively small and include mostly men, the results sug-
gest more coronary atherosclerosis in (the most active) 
athletes whereas plaque morphology appears possibly 
more benign.
Influence of Sex and Race
Limited data are available in female athletes, but small 
studies (n=46 and n=26)5,44 do not suggest increased 
coronary atherosclerosis,5 and possibly suggest a lower 
prevalence of coronary atherosclerosis in female athletes 
compared with controls.44 Supplemental data from De-
Fina et al showed no association between physical ac-
tivity and CACS ≥100 in 9501 women (P=0.91)41. The 
lower prevalence of coronary atherosclerosis in some 
studies of female marathon runners may be a result of 
selection of control subjects, who in one study44 were 
referred for CCTA to evaluate coronary artery disease 
and had significantly higher body mass index, hyper-
tension, hyperlipidemia, smoking history, and family 
history for coronary artery disease. There is insufficient 
data on the association between exercise volumes and 
coronary atherosclerosis characteristics among female 
athletes and studies in male athletes cannot be extrapo-
lated to females. Therefore, the influence of female sex 
is not specifically addressed in the following sections.
Race is known to impact CAC.45 However, most 
studies have evaluated only white individuals. Laddu et 
al performed race-specific analyses and found different 
associations between physical activity and CAC in black 
and white nonathletic subjects,27 suggesting that race 
may affect this association. Consequently, we have not 
addressed the influence of race in the following sec-
tions.
Strength Training
Strength training aims to increase skeletal muscle 
strength and size by repetitively performing anaerobic 
physical activity such as weightlifting. No differences 
were found in the prevalence of CAC and distribution 
of CACS categories between retired American football 
players (n=150, 51±10 years old) and age-matched 
community controls (n=150, 51±10 years old).46 Line-
men, typically the largest players who are often classi-
fied as overweight or obese, had similar CAC prevalence 
compared with nonlinemen.46 However, another study 
comparing linemen with nonlinemen among 931 re-
tired professional American football players (≈54 years 
old) found that the linemen had a higher prevalence 
of CAC and severity of CACS compared with nonline-
men.47 CACS>100 (OR 1.59 [95% CI, 1.01–2.49]) re-
mained more common in the linemen after full adjust-
ment for cardiovascular risk factors and ethnicity.47
The use of performance enhancing drugs may accelerate 
coronary atherosclerosis. Anabolic-androgenic steroid use is 
prevalent among strength-trained athletes, with an estimated 
≈3 million users in the United States.48 Steroids are mainly used 
to increase muscle mass, performance, and personal appear-
ance.48 However, they are also popular among endurance ath-
letes to aid in recovery and strength.49 A pilot study found higher 
CACS than expected, on the basis of reference values from the 
Cooper Clinic, in 14 professional body builders with a long his-
tory of steroid use.50 Seven of 14 (50%) had CAC compared 
with an expected value of 3 (21%). Of those with CAC, 6 of 7 
had CACS >90th percentile. Baggish et al compared coronary 
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atherosclerosis between anabolic steroid using and nonusing 
weightlifters, and nonweightlifting controls.51 Anabolic steroid 
use was associated with increased coronary plaque volume (us-
ers, 3 [0–174] mm3, versus nonusers, 0 [0–69] mm3; P=0.012) 
as was cumulative lifetime duration of use.51 Widespread use of 
anabolic steroids did not appear until the 1980s and 1990s, so 
the long-term atherosclerotic effects are likely to become more 
apparent in the near future, when (ex)users reach middle age 
and beyond.48,51
POTENTIAL EXPLANATIONS 
FOR INCREASED CORONARY 
ATHEROSCLEROSIS IN ATHLETES
The mechanisms underlying increased coronary athero-
sclerosis in athletes are largely unknown, but there are 
several potential pathways, although speculative, that 
may link exercise training to CAC and plaque develop-
ment (Figure 4).
Catecholamines increase heart rate and cardiac con-
tractility during exercise. The exercise-induced increase 
in cardiac output may increase mechanical stress on 
the coronary vessel wall and disrupt laminar blood flow 
patterns, leading to vessel wall injury and accelerated 
atherosclerosis.52 High blood pressure may accelerate 
coronary atherosclerosis,53 and because systolic blood 
pressure increases during exercise, this may contribute 
to accelerated atherosclerosis. The finding that very 
vigorous exercise was associated with atherosclerotic 
plaque and CAC prevalence fits with this hypothesis be-
cause the most intense exercise is associated with the 
greatest increases in both heart rate and systolic blood 
pressure.4
The effects of exercise on vitamins, minerals, and 
hormones, may also influence the association between 
exercise and coronary atherosclerosis. Serum vitamin 
D concentrations are inversely related to CAC,54,55 and 
could accelerate atherosclerosis in athletes who are 
often deficient in vitamin D.56 Similarly, magnesium 
can prevent vascular calcification via multiple mecha-
nisms,57 and serum magnesium concentrations are in-
versely associated with CAC,58 whereas athletes may 
Figure 3. Coronary plaque morphology in athletes.
Panel A illustrates the percentages of different coronary plaque morphologies of the 99 plaques in athletes and 26 plaques in the control subjects (total equals 
100%).5 Panel B illustrates the percentages of different coronary plaque morphologies in athletes with plaques, presented for lifelong exercise volume groups,4 
whereas Panel C illustrates the percentage of athletes with plaques who had only calcified, only noncalcified or only mixed plaque morphology.4 Adapted and 
reprinted with permission from Merghani et al5 (A) and Aengevaeren et al4 (B and C). MET indicates metabolic equivalent of task.
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have low magnesium concentrations.59 Parathyroid 
hormone increases during exercise.60 The increase in 
parathyroid hormone likely follows a decrease in ion-
ized calcium concentration during exercise. The reason 
and fate of the reduced serum concentration of calcium 
are unknown.61 However, higher levels of parathyroid 
hormone are associated with greater atherosclerotic 
disease burden.62 Repeated exposure to higher levels of 
parathyroid levels after exercise may therefore acceler-
ate coronary atherosclerosis in athletes.
Running induces a large pressure concussion wave 
during foot strike, which alters coronary hemodynamics 
and could accelerate coronary atherosclerosis.63,64 This 
effect is also dependent on the timing of steps during 
running with reference to the cardiac cycle.63,64
Inflammation has a major role in the development of 
coronary atherosclerosis and exercise modulates inflam-
mation.65 Chronic exercise lowers inflammation,66 but 
acute exercise can increase inflammation.67 Although 
there is far more evidence supporting a suppression 
of inflammation in athletes, high-intensity, frequent, 
and prolonged exercise could potentially produce an 
inflammatory effect, thereby accelerating coronary ath-
erosclerosis.
Other potential explanations for increased coro-
nary atherosclerosis that have not been sufficiently 
adjusted for in previous studies include dietary intake, 
psychological stress, and genetics. It is also possible that 
performance enhancing drugs or immune-modulating 
medication could contribute to the higher prevalence 
of CAC and plaque among athletes.68
CLINICAL RELEVANCE
Prevalence and severity of CAC and atherosclerotic 
plaques are strongly associated with the 5- and 10-year 
risk of cardiovascular events in the general and patient 
populations,7,8,10,13 yet there is strong evidence that elite 
and amateur athletes live longer than the general pop-
ulation.69,70 Exercise training increases longevity by ap-
proximately 3 to 6 years with the most benefit for ath-
letes performing endurance sports.70,71 The increase in 
cardiorespiratory fitness after aerobic exercise training 
is also positively associated with increased longevity.72
Möhlenkamp et al were the first to examine the 
prognosis of higher CACS in athletes. They followed 
108 marathon runners for 6±1 years and found a high-
er event rate in higher CAC categories (1 of 69 [1%] 
in CAC<100; 3 of 25 [12%] in CAC 100–399; and 3 
of 14 [21%] in CAC ≥400; P=0.002), similar to the ob-
served event rates in their control cohort.73 However, 
this study was limited by the small sample size (n=108) 
and few events (n=7). A more recent study showed 
that the amount of self-reported exercise impacts the 
Figure 4. Potential explanations for increased coronary atherosclerosis in athletes.D
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relationship between CACS and mortality among as-
ymptomatic patients.74 Among individuals with similar 
CACS, performing “no exercise” had a hazard ratio 
(HR) of 2.35 (95% CI, 1.49–3.70) for all-cause mortal-
ity, whereas “low exercise” had an HR of 1.56 (95% 
CI, 1.06–2.30), and “moderate exercise” had an HR 
of 1.29 (95% CI, 0.86–1.95) compared with highly 
active patients (reference group). Similarly, higher car-
diorespiratory fitness significantly reduces the risk of 
cardiovascular events. Lamonte et al showed that in-
dividuals with a fitness ≥10 METs had a 73% reduc-
tion in cardiovascular events compared with those with 
a fitness <10 METs when adjusting for CACS.75 More 
recent data from the Cooper Clinic Longitudinal study 
revealed a reduction of 11% for each additional MET 
of fitness (HR 0.89 [95% CI, 0.84–0.94]) when adjust-
ing for CACS categories (scores of 0, 1–99, 100–399, 
and ≥400).76 In a subsequent publication, DeFina et al 
demonstrated that among individuals with CACS<100, 
those in the highest physical activity category (≥3000 
MET-min/week) had a lower risk of all-cause mortality 
compared with those in the lowest physical activity cat-
egory (<1500 MET-min/week).41 The beneficial associa-
tion between physical activity and all-cause mortality 
was attenuated for individuals with CACS ≥100 (HR 
0.77 [95% CI, 0.52–1.15] for the highest versus the 
lowest physical activity category), whereas CACS≥100 
was more prevalent among the most active individu-
als compared with the less active individuals (RR 1.11 
[95% CI, 1.03–1.20]).
Increases in exercise and cardiorespiratory fitness 
thus seem to lower the cardiovascular risk of CAC. This 
risk reduction may follow from a large coronary flow 
reserve because of a combination of increases in epi-
cardial coronary artery diameter, coronary vasodilatory 
capacity, capillary density, and vasomotor reactivity pro-
duced by exercise training.77–79 Similarly, high-volume 
athletes also have a biological age of their large blood 
vessels that is ≈30 years younger than their chronologi-
cal age,80,81 with substantially improved ventriculo-arte-
rial coupling.82
Coronary atherosclerotic plaques associated with in-
creasing exercise volume may also be more stable and 
less likely to rupture. We found that the most active 
athletes had fewer mixed plaques and more often only 
calcified plaques,4,5 which are associated with a lower 
risk of cardiovascular events.13,15 Similarly, high-intensity 
statin therapy increases CAC, but decreases coronary 
atheroma volume and cardiovascular risk.83 Thus, an in-
crease in CACS may not necessarily reflect an increase 
in cardiovascular risk. Exercise may increase calcifica-
tion similar to the increase observed with statin therapy, 
without an associated increase in cardiovascular risk.
Intimal and medial vascular calcification differ by 
their causal pathways and risk for cardiovascular diseas-
es.84,85 Calcification in an atherosclerotic plaque occurs 
primarily in the intimal layer of the vessel wall and is 
associated with luminal stenosis and potential plaque 
rupture.84 Medial calcification is associated with vessel 
wall stiffening, specifically with aging, chronic kidney 
disease, and metabolic diseases such as disorders of 
calcium and phosphate metabolism.85,86 Athletes may 
be more prone to developing medial rather than inti-
mal calcification through smooth muscle damage in the 
vascular wall or exercise-induced metabolic changes. 
However, the differentiation between intimal and me-
dial calcification cannot be performed reliably using CT, 
and ex vivo histological analysis is the standard.86
Overall, current evidence suggests that higher CACS 
in athletes are similarly associated with an increased 
cardiovascular risk as in a nonathletic cohort. However, 
the absolute risk of CAC is likely lower in athletes as a 
result of several beneficial adaptations (Figure 5). The 
relevance of increased CAC in athletes deserves care-
ful attention and additional longitudinal studies are re-
quired to study the influence of exercise on coronary 
atherosclerosis.
CLINICAL MANAGEMENT
On the basis of our findings, and until the significance 
of coronary calcification in athletes is better defined, 
we do not recommend the routine assessment of CACS 
in athletes based purely on their training history. CAC 
scoring could be considered in asymptomatic individu-
als aged 40 to 75 years with a 10-year atherosclerotic 
CVD risk of 5% to 20% and should be considered only 
in selected individuals with risk below 5%.87 Our gen-
eral guidance is not to repeat CAC scoring, particularly 
in athletes treated with statins, because CACS may in-
crease with statin therapy and continued exercise train-
ing, and CAC does not reverse with aggressive lipid 
therapy.88 Repeated CACS assessment after approxi-
mately 5 to 10 years may provide additional informa-
tion for risk prediction of major cardiovascular events, 
with the most recent CACS providing the best risk es-
timate,89 however this strategy appears only reason-
able for those in whom follow-up results may influence 
treatment.87,90
Treatment should be individualized depending on 
the athlete’s overall risk for cardiovascular disease. All 
athletes should be questioned about symptoms of myo-
cardial ischemia, family history of atherosclerotic coro-
nary artery disease, and current and previous risk fac-
tors. It is important to note that well-trained individuals 
may present with atypical symptoms of coronary ar-
tery disease such as a decline in exercise performance, 
shortness of breath, or fatigue. Symptomatic athletes 
should be investigated and managed in the same fash-
ion as the general population. Asymptomatic athletes, 
including those with high CACS, should be informed 
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that the significance of CAC in middle-aged and older 
athletes is currently unclear.
In athletes with low-density lipoprotein cholesterol 
levels ≥70 mg/dL or ≥1.8 mmol/L, and CACS ≥100 
or ≥75th percentile compared with their age and sex 
matched, nonathletic peers, statin therapy should be 
considered after atherosclerotic CVD risk calculation 
and clinician-patient risk discussion.90,91 Risk enhancers 
such as extensive (noncalcified) atherosclerotic plaque 
on CCTA or a strong family history for premature 
CVD support initiating statin therapy. The American 
guidelines for lipid management favor statin therapy 
when CACS>0 if the 10-year atherosclerotic CVD risk 
is ≥7.5%.90 However, this cut point is very sensitive to 
the scoring system used. Given that the CACS is known 
in these individuals, the ASTRO-CHARM (Astronaut 
Cardiovascular Health and Risk Modification) risk cal-
culator can be used,92 which incorporates CACS and 
calculates 10-year risk of fatal or nonfatal myocardial 
infarction or stroke. Athletes with CACS ≥400 should 
be advised to commence high-intensity statin therapy 
and other atherosclerotic risk factors should be strictly 
managed. Aspirin may be considered for individuals not 
at increased bleeding risk.93 Episodic use of aspirin (eg, 
prerace) has been suggested to prevent exercise-related 
sudden cardiac arrests,94 although evidence for this ap-
proach is lacking.
Because CAC scoring is not routinely recommended, 
the current guidelines do not clearly indicate how to pro-
ceed with additional testing in asymptomatic athletes with 
high CACS.95,96 The following options can be considered 
when evaluating an asymptomatic athlete. Management 
strategies differ per region in the world (eg, United States 
versus Europe), country, and even per physician. Addition-
al testing strongly depends on hospital logistics, costs, and 
availability of tests. CCTA may be considered in athletes 
with CAC to assess the number and nature of coronary 
plaques and to quantify the degree of luminal narrowing. 
In some hospitals, all individuals with a CACS>0 proceed 
to CCTA. Exercise or pharmacological stress testing may 
also be considered to check for inducible myocardial isch-
emia. In individuals with CACS ≥400 and/or luminal ste-
noses >50% an exercise stress test or stress imaging tests 
should be considered to detect evidence of ischemia. Evi-
dence of ischemia could prompt coronary intervention or 
provide guidance for setting exercise heart rate limits, sug-
gest modification of training, and prompt consideration 
of additional preventive therapy such as beta blockers. 
Some physicians may proceed to invasive coronary angi-
ography with fractional flow reserve measurements. In the 
future, CCTA-based fractional flow reserve measurements 
Figure 5. The benefits and risks of long-term exercise training on coronary function, morphology, and atherosclerosis.
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may lower the need for invasive coronary angiography. At 
present, there are insufficient data to provide definitive 
recommendations for additional testing in asymptomatic 
athletes with CAC.
American97 and European98 guidelines are available 
for exercise recommendations in athletes with subclini-
cal coronary artery disease and many of such athletes 
are detected by CAC scoring. These recommendations 
generally allow participation in all sports, even in ath-
letes with high CACS, if the athlete is asymptomatic, has 
no evidence of ischemia or electric instability, and has a 
normal ejection fraction. As such, athletes can continue 
their exercise training despite a high CACS. Although the 
most active individuals with CACS≥100 did not have a 
higher risk for (cardiovascular) mortality compared with 
less active individuals with similar CACS,41 presence of 
CAC is strongly associated with clinical outcomes, in ath-
letes as well as less active individuals. Because exercise 
does appear to increase CAC, future longitudinal studies 
are required to confirm this recommendation.
FUTURE RESEARCH
Future longitudinal studies are necessary to further in-
vestigate the association between exercise training and 
the development and progression of coronary athero-
sclerosis among athletes and its clinical relevance. Also, 
more insight is needed into the mechanisms responsible 
for increased coronary atherosclerosis in athletes. In this 
regard, the emerging ability of CT to identify coronary 
inflammation through measuring the perivascular fat 
attenuation index may provide additional informa-
tion regarding the link between exercise and coronary 
atherosclerosis.99 Most studies included primarily male 
white runners so little is known on how exercise affects 
coronary atherosclerosis in females, different ethnicities, 
and across sporting disciplines. Future ultralow dose CT-
scanning will make assessment of CACS more feasible 
by lowering the radiation exposure in healthy subjects.100 
Furthermore, the current CAC scoring using the Ag-
atston score may be refined in the future because it has 
been shown that the volume and density components 
have different associations with cardiovascular events. 
Other potentially meaningful characteristics of calcifica-
tions such as number of lesions, location, or distribution 
may be added in such a new CAC scoring method.6
CONCLUSIONS
Studies investigating the relationship between physi-
cal activity/exercise and coronary atherosclerosis in 
the general population have revealed mixed results 
that show no clear net effect. However, studies in 
athletes have demonstrated a higher prevalence 
of CACS≥100 compared with less active controls. 
Increased coronary atherosclerosis in athletes may 
be mediated via several mechanisms. The clinical rel-
evance of increased coronary atherosclerosis in ath-
letes is unclear, but the absence of CAC or plaque 
is better than the presence of any atherosclerosis. 
Higher CACS among athletes may not necessarily 
reflect an increased risk for cardiovascular events 
similar to the general population because exercise 
promotes beneficial coronary adaptations and in-
creased calcification may be associated with plaque 
stabilization, which likely explains some of the sig-
nificant reduction in cardiovascular events because 
of exercise training. Statin therapy and intensive risk 
factor management are recommended for athletes 
with CAC, depending on their CACS and estimated 
10-year atherosclerotic cardiovascular disease risk, 
to stabilize plaques and prevent coronary events. Fu-
ture longitudinal studies are anticipated to further 
investigate the role of exercise in coronary athero-
sclerosis.
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